169750-01-0

Basic information

• Product Name: 3-(N-TERT-BUTOXYCARBONYL-N-METHYLAMINO)PYRROLIDINE
• Synonyms: (3S)-3-Amino-N-methylpyrrolidine, N-BOC protected;-tert-Butyl methyl(pyrrolidin-3-yl);3-(N-METHYL-N-BOC-AMINO)PYRROLIDINE;3-(N-METHYL-N-TERT-BUTOXYCARBONYLAMINO)PYRROLIDINE;3-(N-BOC-N-METHYLAMINO)PYRROLIDINE;(3S)-3-[N-(tert-Butoxycarbonyl)-N-methylamino]pyrrolidine;(S)-3-(N-BOCMETHYLAMINO)PYRROLIDINE;(S)-3-[N-(tert-Butoxycarbonyl)-N-methylamino]pyrrolidine
• CAS NO: 169750-01-0
• Molecular Formula: C₁₀H₂₀N₂O₂
• Molecular Weight: 200.28
• Mol File: 169750-01-0.mol

Chemical Properties

• Boiling Point: 268℃
• Flash Point: 116℃
• Appearance: /
• Density: 1.03
• Refractive Index: 1.48
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 9.85±0.10(Predicted)
• CAS DataBase Reference: 3-(N-TERT-BUTOXYCARBONYL-N-METHYLAMINO)PYRROLIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(N-TERT-BUTOXYCARBONYL-N-METHYLAMINO)PYRROLIDINE(169750-01-0)
• EPA Substance Registry System: 3-(N-TERT-BUTOXYCARBONYL-N-METHYLAMINO)PYRROLIDINE(169750-01-0)

Safety Data

• Hazardous Substances Data: 169750-01-0(Hazardous Substances Data)

Usage

Uses

Used in Organic Chemistry:
3-(N-TERT-BUTOXYCARBONYL-N-METHYLAMINO)PYRROLIDINE is used as a protecting group for the amine group of amino acids during peptide synthesis for its ability to shield the reactive amine group, allowing for selective and efficient chemical reactions to occur without unwanted side reactions.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 3-(N-TERT-BUTOXYCARBONYL-N-METHYLAMINO)PYRROLIDINE is used as a key intermediate in the synthesis of peptide-based drugs, facilitating the production of complex peptide structures with high purity and yield. Its selective removal under mild conditions ensures the integrity of the final peptide product, contributing to the development of effective therapeutic agents.
Used in Research and Development:
3-(N-TERT-BUTOXYCARBONYL-N-METHYLAMINO)PYRROLIDINE is utilized in research and development for the exploration of novel peptide sequences and their potential applications in medicine and biotechnology. Its role in protecting the amine group of amino acids during synthesis allows for the investigation of various peptide modifications and their effects on biological activity and stability.

InChI:InChI=1/C10H20N2O2/c1-10(2,3)14-9(13)7-12-8-4-5-11-6-8/h8,11-12H,4-7H2,1-3H3/t8-/m0/s1

Upstream product

• 172477-98-4 1-benzyl-3-<(t-butyloxycarbonyl)methylamino>-pyrrolidine 
• 1412254-93-3 benzyl (3S)-3-[tert-butoxycarbonyl(methyl)amino]pyrrolidine-1-carboxylate 
• 122536-74-7 (S)-3-<<(1,1-dimethylethoxy)carbonyl>amino>-1-pyrrolidinecarboxylic acid phenylmethyl ester 
• 122536-76-9 3(S)-(tert-butoxycarbonylamino)pyrrolidine 
• 169749-99-9 (3S)-(-)-1-benzyl-3-(methylamino)pyrrolidine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 169750-00-9 (S)-1-benzyl-3-[[N-(t-butoxycarbonyl)]-N-methylamino]pyrrolidine 
• 96568-35-3 1-benzyl-3-(methylamino)pyrrolidine 

Downstream Products

• 863401-94-9 tert-butyl methyl(1-(5-nitropyridin-2-yl)pyrrolidin-3-yl)carbamate 
• 946056-08-2 (1-{5-[(biphenyl-4-carbonyl)-amino]-pyridin-2-yl}-pyrrolidin-3-yl)-methyl-carbamic acid tert-butyl ester 
• 863401-75-6 methyl-[1-(4-nitro-phenyl)-pyrrolidin-3-yl]-carbamic acid tert-butyl ester 
• 643087-83-6 tert-butyl [1-(4-aminophenyl)pyrrolidin-3-yl]methylcarbamate 
• 863401-89-2 biphenyl-4-carboxylic acid [4-(3-methylamino-pyrrolidin-1-yl)-phenyl]-amide 
• 863401-88-1 (1-{4-[(biphenyl-4-carbonyl)-amino]-phenyl}-pyrrolidin-3-yl)-methyl-carbamic acid tert-butyl ester 
• 172478-04-5 3-methylamino-1-propionyl-pyrrolidine 
• 838871-78-6 tert-butyl {1-[2-amino-6-(3-cyanophenyl)pyrimidin-4-yl]-pyrrolidin-3-yl}methylcarbamate 
• 762285-60-9 C₁₉H₃₀N₂O₂ 
• 859731-43-4 2-(3-(R/S)-(((tert-butoxycarbonyl)amino)methyl)-pyrrolidin-1-yl)-4-(4-methoxybenzyl)-7-oxo-4,7-dihydro[1,3]thiazolo[4,5-b]pyridine-6-carboxylic acid 
• 895571-39-8 (1-{2-[7-(3-fluoro-benzenesulfonyl)-chroman-4-yl]-ethyl}-pyrrolidin-3-yl)-methyl-carbamic acid tert-butyl ester 
• 748183-11-1 tert-Butyl [1-(4-amino-2-chloro-3-fluorophenyl)pyrrolidin-3-yl]methylcarbamate 

Relevant articles and documents

Discovery of DS34942424: An orally potent analgesic without mu opioid receptor agonist activity

We identified (5′S)-10′-fluoro-6′-methyl-5′,6′-dihydro-3′H-spiro[cyclopropane-1,4′-[2,6]diaza[2,5]methano[2,6]benzodiazonin]-7′(1′H)-one, 22b (DS34942424) with a unique and original bicyclic skeleton. 22b showed an orally potent analgesic in the acetic ac

TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS

Compounds of Formula I: in which R1, R2, R3, R4 and R10 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of diseases mediated by PIM-1 and/or PIM-2 and/or PIM-3 kinases.

2 -AMINO-PYRIMIDINE DERIVATIVES AS HISTAMINE H4 ANTAGONISTS

2-Aminopyrimidine derivatives of formula (I), wherein the meaning of the different substituents are those indicated in the description. These compounds are useful as histamine H4 receptor antagonists.

DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS

Provided herein are compounds of the formula (I) as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity, type II diabetes mellitus and metabolic syndrome.

Quinolinone-carboxamide compounds

The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.

Indazole-carboxamide compounds

The invention provides novel indazole-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.

5-HT4 receptor agonist compounds

The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.

Quinolinone compounds as 5-HT4 receptor agonists

The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.

Synthesis and structure-activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 2

The design, synthesis, and SAR of a series of retro bis-aminopyrrolidine ureas are described. Compounds from this series exhibited considerable binding affinity (Ki = 1 nM) and functional activity at MCH-R1, acceptable CYP2D6 inhibition, and good rat brain exposure.

AMIDE DERIVATIVE AND MEDICINE

The present invention is directed to an amide derivative having excellent BCR-ABL tyrosine kinase inhibitory activity, or a salt thereof. The present invention provides an amide derivative represented by the following general formula [1]: (wherein R1 represents -CH2-R11, etc.; R2 represents alkyl, halogen, haloalkyl, etc.; R3 represents hydrogen, etc.; Het1 represents a group of the formula [6] as above, etc.; and Het2 represents pyrimidinyl, etc.), or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same as an active ingredient. The compound of the present invention is useful as a BCR-ABL tyrosine kinase inhibitor.